#nitisinone

"One way to stop the spread of diseases transmitted by insects is to make the blood of animals and humans toxic," according to researchers. Researchers have discovered that a medication typically prescribed for rare diseases could make human blood deadly for mosquitoes, offering a potential lead to curb diseases such as malaria. They experimented with a drug called nitisinone, which is usually prescribed to individuals with rare inherited diseases that typically prevent them from being able to fully break down certain amino acids. The medication works by blocking an enzyme to prevent the build-up of harmful disease byproducts in the human body. When mosquitoes drink blood that contains nitisinone, the drug also blocks the enzyme in their bodies, stopping them from properly digesting the blood, leading them to quickly die, according to their findings published in the journal Science Translational Medicine. "One way to stop the spread of diseases transmitted by insects is to make the blood of animals and humans toxic to these blood-feeding insects," Lee R Haines, associate research professor at the University of Notre Dame in the US and co-lead author of the study, said in a statement. "Our findings suggest that using nitisinone could be a promising new complementary tool for controlling insect-borne diseases like malaria". Personal protective measures include wearing covering clothes, the use of mosquito repellent and the use of bed nets or window and door screens.

Hereditary Tyrosinemia Type 1 (HT-1) is a rare genetic disorder that affects the way the body breaks down the amino acid tyrosine. Without treatment, HT-1 can lead to serious liver and kidney complications. Early diagnosis and effective treatment with Nitisinone can significantly improve the quality of life for those affected by HT-1.

At Indian Generic Medicines, we supply affordable and high-quality Nitisinone to support patients battling HT-1 across the globe. Together, we can raise awareness and make treatment more accessible.

Nitisinone is used to treat Hereditary tyrosinemia type 1 (HT-1), a rare hereditary disease. It stops the enzyme from producing the toxic byproducts connected to HT-1. In addition to nitisinone, dietary limitations for phenylalanine and tyrosine are typically recommended. Patients on HT-1 had a lower risk of renal and liver damage. It is crucial to routinely assess the plasma and blood cell counts' tyrosine levels. The most common side effects include thrombocytopenia, leukopenia, and vision problems. 

Since nitisinone cost in India is inexpensive, incorporating it into daily routines is made simpler. One trustworthy supplier of the medication is Indian Pharma.